Virios Therapeutics, Inc. (DWTX)
NASDAQ: DWTX · Real-Time Price · USD
2.830
-1.045 (-26.97%)
At close: Oct 9, 2024, 4:00 PM
2.800
-0.030 (-1.06%)
After-hours: Oct 9, 2024, 7:59 PM EDT
Virios Therapeutics Statistics
Total Valuation
DWTX has a market cap or net worth of $3.77 million. The enterprise value is $750,138.
Market Cap | 3.77M |
Enterprise Value | 750,138 |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
DWTX has 1.33 million shares outstanding. The number of shares has increased by 25.11% in one year.
Shares Outstanding | 1.33M |
Shares Change (YoY) | +25.11% |
Shares Change (QoQ) | +18.92% |
Owned by Insiders (%) | 140.39% |
Owned by Institutions (%) | 74.20% |
Float | 25.89M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 1.00 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.27
Current Ratio | 7.27 |
Quick Ratio | 6.04 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -119.56% and return on invested capital (ROIC) is -76.59%.
Return on Equity (ROE) | -119.56% |
Return on Assets (ROA) | -67.76% |
Return on Capital (ROIC) | -76.59% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.17M |
Employee Count | 4 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -86.05% in the last 52 weeks. The beta is 1.58, so DWTX's price volatility has been higher than the market average.
Beta (5Y) | 1.58 |
52-Week Price Change | -86.05% |
50-Day Moving Average | 4.62 |
200-Day Moving Average | 8.30 |
Relative Strength Index (RSI) | 30.95 |
Average Volume (20 Days) | 117,340 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -4.80M |
Pretax Income | n/a |
Net Income | -4.68M |
EBITDA | n/a |
EBIT | -4.80M |
Earnings Per Share (EPS) | -$5.81 |
Balance Sheet
Cash & Cash Equivalents | 3.02M |
Total Debt | n/a |
Net Cash | 3.02M |
Net Cash Per Share | $2.27 |
Equity (Book Value) | 3.14M |
Book Value Per Share | 2.82 |
Working Capital | 3.14M |
Cash Flow
Operating Cash Flow | -4.18M |
Capital Expenditures | n/a |
Free Cash Flow | -4.18M |
FCF Per Share | -$3.14 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
DWTX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -25.11% |
Shareholder Yield | -25.11% |
Earnings Yield | -124.11% |
FCF Yield | -110.83% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on October 9, 2024. It was a reverse split with a ratio of 0.04:1.
Last Split Date | Oct 9, 2024 |
Split Type | Reverse |
Split Ratio | 0.04:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |